Spotlight on the Sirolimus-Eluting Stent in Coronary Artery Disease

ISSN： 1175-9038

Source： American Journal of Drug Delivery, Vol.2, Iss.1, 2004-01, pp. : 69-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Sirolimus-Eluting Stent: A Review of Its Use in the Treatment of Coronary Artery Disease

By McKeage K. Murdoch D. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 3, 2003-01 ,pp. : 211-230

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior for coronary artery restenosis prevention

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent reduces restenosis, coronary events

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior in diabetes

Inpharma, Vol. 1, Iss. 1461, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite